Quinoxaline-2,3-dione compounds and their preparation and use
US5166155A · kind A · utility
16Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 12, 1991 |
| Grant date | Nov 24, 1992 |
| Priority date | — |
| Expiry date | Mar 12, 2011 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D241/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
1-carboxyalkylquinoxaline-2,3(1H,4H)-dione compounds or tautomeric forms thereof of the formula ##STR1## wherein R represents hydrogen, C.sub.1-6 -alkyl, including branched chains, or aralkyl and n represents the number from 0 to 5; PA0 R.sup.4 represents hydrogen or hydroxy; PA0 R.sup.5, R.sup.6, R.sup.7 and R.sup.8 independently represent hydrogen, nitro, halogen, alkoxy, aryloxy, aralkoxy, C.sub.1-6 -alkyl including branched chains, or aryl; PA0 R.sup.9 represents hydrogen, lower alkyl, or aryl; PA0 R.sup.10 represents hydrogen, or alkyl. The compounds are useful in the treatment of neurological and psychiatric diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.